NO20022253L - Middel til behandling av hepatitt C - Google Patents
Middel til behandling av hepatitt CInfo
- Publication number
- NO20022253L NO20022253L NO20022253A NO20022253A NO20022253L NO 20022253 L NO20022253 L NO 20022253L NO 20022253 A NO20022253 A NO 20022253A NO 20022253 A NO20022253 A NO 20022253A NO 20022253 L NO20022253 L NO 20022253L
- Authority
- NO
- Norway
- Prior art keywords
- hepatitis
- agent
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0048100A AT408719B (de) | 2000-03-22 | 2000-03-22 | Mittel zur behandlung von hepatitis c |
PCT/AT2001/000076 WO2001070203A2 (de) | 2000-03-22 | 2001-03-20 | Mittel zur behandlung von hepatitis c, enthaltend ukrain |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022253D0 NO20022253D0 (no) | 2002-05-10 |
NO20022253L true NO20022253L (no) | 2002-05-10 |
Family
ID=3674939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022253A NO20022253L (no) | 2000-03-22 | 2002-05-10 | Middel til behandling av hepatitt C |
Country Status (17)
Country | Link |
---|---|
JP (1) | JP2003527414A (no) |
KR (1) | KR20020087045A (no) |
CN (1) | CN1416347A (no) |
AT (1) | AT408719B (no) |
AU (1) | AU2001239000A1 (no) |
BG (1) | BG107088A (no) |
BR (1) | BR0107211A (no) |
CA (1) | CA2389173A1 (no) |
EA (1) | EA200200584A1 (no) |
HR (1) | HRP20020367A2 (no) |
IL (1) | IL149314A0 (no) |
IS (1) | IS6360A (no) |
MA (1) | MA25509A1 (no) |
MX (1) | MXPA02004993A (no) |
NO (1) | NO20022253L (no) |
PL (1) | PL365000A1 (no) |
WO (1) | WO2001070203A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695417A5 (de) * | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
EP1459753A1 (en) | 2003-03-18 | 2004-09-22 | Nowicky, Wassyl, Dipl.-Ing. DDr. | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
CA2664935A1 (en) * | 2006-09-26 | 2008-04-03 | Addiction Research Institute, Inc. | Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c |
CN106343303A (zh) * | 2015-07-13 | 2017-01-25 | 张如安 | 灭杀乙肝病毒的饮料 |
CN106109538A (zh) * | 2016-07-29 | 2016-11-16 | 桂林淮安天然保健品开发有限公司 | 治疗丙肝的药物组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3128018A1 (de) * | 1981-07-13 | 1983-04-07 | Wassyl 1060 Wien Nowicky | "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze" |
US4816462A (en) * | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
-
2000
- 2000-03-22 AT AT0048100A patent/AT408719B/de not_active IP Right Cessation
-
2001
- 2001-03-20 KR KR1020027005739A patent/KR20020087045A/ko not_active Application Discontinuation
- 2001-03-20 BR BR0107211-0A patent/BR0107211A/pt not_active IP Right Cessation
- 2001-03-20 CN CN01803046A patent/CN1416347A/zh active Pending
- 2001-03-20 AU AU2001239000A patent/AU2001239000A1/en not_active Abandoned
- 2001-03-20 JP JP2001568401A patent/JP2003527414A/ja active Pending
- 2001-03-20 CA CA002389173A patent/CA2389173A1/en not_active Abandoned
- 2001-03-20 WO PCT/AT2001/000076 patent/WO2001070203A2/de active Application Filing
- 2001-03-20 MX MXPA02004993A patent/MXPA02004993A/es unknown
- 2001-03-20 IL IL14931401A patent/IL149314A0/xx unknown
- 2001-03-20 EA EA200200584A patent/EA200200584A1/ru unknown
- 2001-03-20 PL PL01365000A patent/PL365000A1/xx not_active Application Discontinuation
-
2002
- 2002-04-24 IS IS6360A patent/IS6360A/is unknown
- 2002-04-26 HR HR20020367A patent/HRP20020367A2/hr not_active Application Discontinuation
- 2002-05-10 NO NO20022253A patent/NO20022253L/no unknown
- 2002-05-28 MA MA26657A patent/MA25509A1/fr unknown
- 2002-09-12 BG BG107088A patent/BG107088A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001070203A2 (de) | 2001-09-27 |
BR0107211A (pt) | 2004-01-06 |
JP2003527414A (ja) | 2003-09-16 |
MXPA02004993A (es) | 2003-10-14 |
IL149314A0 (en) | 2002-11-10 |
CN1416347A (zh) | 2003-05-07 |
AU2001239000A1 (en) | 2001-10-03 |
BG107088A (en) | 2003-05-30 |
PL365000A1 (en) | 2004-12-27 |
CA2389173A1 (en) | 2001-09-27 |
HRP20020367A2 (en) | 2004-02-29 |
ATA4812000A (de) | 2001-07-15 |
NO20022253D0 (no) | 2002-05-10 |
KR20020087045A (ko) | 2002-11-21 |
EA200200584A1 (ru) | 2003-06-26 |
AT408719B (de) | 2002-02-25 |
WO2001070203A3 (de) | 2002-09-06 |
IS6360A (is) | 2002-04-24 |
MA25509A1 (fr) | 2002-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
IS6917A (is) | Epóþílon afleiður til meðhöndlunar erfiðra æxla | |
DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
NO20040253L (no) | Fremgangsmater for behandling av leverfibroser | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
DK1197485T3 (da) | Cyclobutendionderivater til behandling af artherosclerose | |
DK1200114T3 (da) | PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
NO20022253D0 (no) | Middel til behandling av hepatitt C | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin |